Osaic Holdings’s Biocept, Inc. BIOC Stock Holding History

Osaic Holdings’s Portfolio BIOC Stock Details BIOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-33	Closed	-$41	–	7637
2023 Q3	$41	Hold	33	–	–	﹤0.01%	7286
2023 Q2	$40	Hold	33	–	–	﹤0.01%	7341
2023 Q1	$340	Sell	33 -34	-51%	-$492	﹤0.01%	7199
2022 Q4	$1K	Sell	67 -166	-71%	-$3.66K	﹤0.01%	7052
2022 Q3	$6K	Hold	233	–	–	﹤0.01%	6330
2022 Q2	$7K	Sell	233 -104	-31%	-$4.74K	﹤0.01%	6350
2022 Q1	$23K	Buy	337 +84	+33%	+$6.6K	﹤0.01%	5619
2021 Q4	$27K	Hold	253	–	–	﹤0.01%	5600
2021 Q3	$30K	Buy	253 +20	+9%	+$2.33K	﹤0.01%	5496
2021 Q2	$29K	Hold	233	–	–	﹤0.01%	5432
2021 Q1	$36K	Hold	233	–	–	﹤0.01%	5117
2020 Q4	$31K	Sell	233 -100	-30%	-$14.3K	﹤0.01%	4901
2020 Q3	$44K	Buy	333 +166	+99%	+$33.5K	﹤0.01%	4406
2020 Q2	$36K	Hold	167	–	–	﹤0.01%	4425
2020 Q1	$13K	Buy	+167	New	+$17.1K	﹤0.01%	4887

Osaic Holdings's BIOC Position: Q4 2023 in Review

Osaic Holdings sold out of Biocept, Inc. (BIOC) in Q4 2023, closing a stake of 33 shares — an estimated $41 sold.

Osaic Holdings first reported a position in BIOC in Q1 2020 and held it in 15 quarters. The position peaked at $44K in Q3 2020. 0 funds tracked by Wall St. Rank hold BIOC as of Q4 2023.

Osaic Holdings reported no remaining Biocept, Inc. position as of Q4 2023 after selling out during the quarter.
Osaic Holdings sold 33 Biocept, Inc. shares in Q4 2023, an estimated $41.
Osaic Holdings first reported a position in Biocept, Inc. in Q1 2020 and held it in 15 quarters.
Osaic Holdings's Biocept, Inc. position peaked at $44K in Q3 2020.
0 funds tracked by Wall St. Rank held Biocept, Inc. as of Q4 2023.

Based on Osaic Holdings's 13F filing for Q4 2023, filed 12 Feb 2024.